Grantham, Mayo, Van Otterloo & Co (GMO)’s Nasdaq NDAQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,487
Closed -$568K 662
2025
Q1
$568K Sell
7,487
-2,701
-27% -$213K ﹤0.01% 535
2024
Q4
$788K Buy
10,188
+4,361
+75% +$337K ﹤0.01% 469
2024
Q3
$425K Sell
5,827
-6,630
-53% -$453K ﹤0.01% 497
2024
Q2
$751K Sell
12,457
-17,315
-58% -$1.05M ﹤0.01% 423
2024
Q1
$1.88M Buy
29,772
+83
+0.3% +$4.8K 0.01% 368
2023
Q4
$1.73M Sell
29,689
-5,923
-17% -$312K 0.01% 355
2023
Q3
$1.73M Buy
+35,612
New +$1.8M 0.01% 416
2022
Q1
Sell
-5,826
Closed -$408K 742
2021
Q4
$408K Buy
+5,826
New +$397K ﹤0.01% 619
2021
Q2
Sell
-16,026
Closed -$788K 808
2021
Q1
$788K Buy
16,026
+2,400
+18% +$114K ﹤0.01% 629
2020
Q4
$603K Hold
13,626
﹤0.01% 652
2020
Q3
$557K Buy
+13,626
New +$581K ﹤0.01% 609
2017
Q2
Sell
-181,872
Closed -$4.21M 616
2017
Q1
$4.21M Sell
181,872
-825,891
-82% -$19.2M 0.02% 256
2016
Q4
$22.5M Sell
1,007,763
-718,893
-42% -$15.9M 0.12% 137
2016
Q3
$38.9M Sell
1,726,656
-649,041
-27% -$15M 0.18% 124
2016
Q2
$51.2M Buy
2,375,697
+937,572
+65% +$20M 0.21% 104
2016
Q1
$31.8M Buy
1,438,125
+854,340
+146% +$17.6M 0.12% 153
2015
Q4
$11.3M Buy
583,785
+80,100
+16% +$1.53M 0.04% 191
2015
Q3
$8.95M Buy
503,685
+422,685
+522% +$7.25M 0.03% 200
2015
Q2
$1.32M Sell
81,000
-15,300
-16% -$257K ﹤0.01% 350
2015
Q1
$1.64M Buy
96,300
+6,300
+7% +$103K ﹤0.01% 340
2014
Q4
$1.44M Sell
90,000
-11,100
-11% -$163K ﹤0.01% 348
2014
Q3
$1.43M Buy
101,100
+34,500
+52% +$484K ﹤0.01% 372
2014
Q2
$857K Sell
66,600
-4,800
-7% -$58.7K ﹤0.01% 417
2014
Q1
$879K Sell
71,400
-16,776
-19% -$217K ﹤0.01% 482
2013
Q4
$1.17M Sell
88,176
-33,414
-27% -$409K ﹤0.01% 448
2013
Q3
$1.3M Buy
121,590
+25,458
+26% +$272K ﹤0.01% 442
2013
Q2
$1.05M Buy
+96,132
New +$980K ﹤0.01% 458

Other funds holding NDAQ

Grantham, Mayo, Van Otterloo & Co (GMO)'s NDAQ Position: Q2 2025 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Nasdaq (NDAQ) in Q2 2025, closing a stake of 7,487 shares — an estimated $568K sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in NDAQ in Q2 2013 and held it in 27 quarters. The position peaked at $51.2M in Q2 2016. 1,018 funds tracked by Wall St. Rank hold NDAQ as of Q2 2025.

  • Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Nasdaq position as of Q2 2025 after selling out during the quarter.
  • Grantham, Mayo, Van Otterloo & Co (GMO) sold 7,487 Nasdaq shares in Q2 2025, an estimated $568K.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Nasdaq in Q2 2013 and held it in 27 quarters.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Nasdaq position peaked at $51.2M in Q2 2016.
  • 1,018 funds tracked by Wall St. Rank held Nasdaq as of Q2 2025.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q2 2025, filed 13 Aug 2025.